Skip to main content

Want a detailed portfolio tracker?

Coeptis Therapeutics Holdings Inc. Common Stock (COEP) P/E (2021 - 2022)

Coeptis Therapeutics Holdings Inc. Common Stock (COEP) P/E from Mar 31, 2021 to Oct 28, 2022. The TTM Coeptis Therapeutics Holdings Inc. Common Stock (COEP) P/E is 4.33. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Coeptis Therapeutics Holdings Inc. Common Stock (COEP)

YearP/EChange
20224.33+488.15%
20210.74N/A

Comparison Coeptis Therapeutics Holdings Inc. Common Stock (COEP) P/E with competitors

Coeptis Therapeutics Holdings Inc. Common Stock (COEP) P/E is 4.33.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-99.96%
NBYStablecoin Development Corp0.10-97.64%
ENLVEnlivex Therapeutics Ltd0.15-96.53%
FGENFibroGen Inc0.24-94.46%
TRAWTraws Pharma Inc0.47-89.09%
FBIOFortress Biotech Inc0.71-83.70%
CHRSCoherus Biosciences Inc0.98-77.42%
ORMPOramed Pharmaceuticals Inc1.47-65.99%
AGENAgenus Inc2.05-52.71%
VIVSVivoSim Labs Inc2.54-41.46%
INVAInnoviva Inc3.19-26.40%
CRMDCorMedix Inc3.65-15.84%
ABEOAbeona Therapeutics Inc4.20-2.93%
VXRTVaxart Inc4.26-1.63%
CVACCureVac N.V.4.45+2.62%
SRPTSarepta Therapeutics Inc4.62+6.75%
GLPGGalapagos NV4.86+12.16%
RIGLRigel Pharmaceuticals4.92+13.56%
ZVRAZevra Therapeutics Inc4.97+14.82%
ABUSArbutus Biopharma Corp5.69+31.43%
CGENCompugen Ltd7.38+70.45%
AUPHAurinia Pharmaceuticals Inc9.25+113.56%
ACADAcadia Pharmaceuticals Inc9.59+121.33%
OMEROmeros Corporation9.88+128.15%
PLXProtalix BioTherapeutics Inc9.91+128.75%
SPROSpero Therapeutics Inc10.73+147.80%
ADMAAdma Biologics Inc11.33+161.56%
SVASinovac Biotech Ltd11.44+163.99%
TBPHTheravance Biopharma Inc11.78+171.86%
HRMYHarmony Biosciences Holdings Inc12.18+181.18%
TGTXTG Therapeutics Inc13.18+204.24%
INCYIncyte Corp13.38+208.92%
SABSSAB Biotherapeutics Inc14.06+224.51%
XOMAXOMA Corp14.95+245.00%
REGNRegeneron Pharmaceuticals Inc14.98+245.81%
PBYIPuma Biotechnology Inc15.05+247.43%
EXELExelixis Inc15.79+264.61%
NAGENiagen Bioscience Inc16.35+277.54%
CPRXCatalyst Pharmaceuticals Inc17.34+300.39%
MDXGMimedx Group Inc17.38+301.10%
ARGXArgen X SE23.07+432.59%
HALOHalozyme Therapeutics Inc23.20+435.57%
XOMAOXOMA Corp25.34+485.07%
VRTXVertex Pharmaceuticals Inc25.66+492.25%
XOMAPXOMA Corp25.67+492.58%
CTMXCytomX Therapeutics Inc25.70+493.22%
ASNDAscendis Pharma A/S26.35+508.37%
RPRXRoyalty Pharma plc - Class A27.50+534.72%
SLNOSoleno Therapeutics Inc29.02+569.80%
LGNDLigand Pharmaceuticals Inc - Class B30.19+596.84%
BMRNBiomarin Pharmaceutical Inc37.51+765.83%
APLSApellis Pharmaceuticals Inc39.02+800.78%
KRYSKrystal Biotech Inc39.70+816.40%
GMABGenmab40.20+828.08%
ONCBeiGene Ltd67.03+1447.28%
TECHBio-Techne Corp68.59+1483.48%
VCELVericel Corp80.63+1761.28%
PHARPharming Group N.V.87.74+1925.43%
ALNYAlnylam Pharmaceuticals Inc124.93+2784.02%
TLXTelix Pharmaceuticals Ltd139.89+3129.30%
CORTCorcept Therapeutics Inc158.39+3556.33%